Craig Bijou
Stock Analyst
(n/a)
# 603
Out of 4,648 analysts
56
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by Craig Bijou
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IART Integra LifeSciences Holdings | Maintains: Underperform | $26 → $18 | $24.12 | -25.37% | 13 | Oct 7, 2024 | |
| ITGR Integer Holdings | Maintains: Buy | $135 → $145 | $126.53 | +14.60% | 3 | Oct 1, 2024 | |
| MMSI Merit Medical Systems | Maintains: Neutral | $92 → $103 | $99.08 | +3.96% | 3 | Sep 16, 2024 | |
| HAE Haemonetics | Initiates: Neutral | $85 | $73.53 | +15.60% | 1 | Sep 11, 2024 | |
| PRCT PROCEPT BioRobotics | Maintains: Buy | $80 → $94 | $97.07 | -3.16% | 3 | Aug 22, 2024 | |
| GEHC GE HealthCare Technologies | Maintains: Neutral | $94 → $86 | $86.99 | -1.14% | 2 | May 1, 2024 | |
| COO The Cooper Companies | Initiates: Buy | $95 | $104.86 | -9.40% | 1 | Oct 30, 2023 | |
| TFX Teleflex | Maintains: Neutral | $265 | $207.33 | +27.82% | 4 | Aug 3, 2023 | |
| BLCO Bausch + Lomb | Maintains: Buy | $19 → $23 | $19.87 | +15.75% | 1 | Jul 3, 2023 | |
| GMED Globus Medical | Downgrades: Underperform | $83 → $63 | $74.72 | -15.69% | 2 | Feb 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $25 | $6.06 | +312.54% | 1 | Mar 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $43 → $36 | $13.63 | +164.12% | 2 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $23 → $45 | $9.12 | +393.42% | 3 | May 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $1 → $8 | $0.87 | +818.48% | 2 | Mar 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $30 | $12.32 | +143.51% | 5 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $17 → $13 | $10.32 | +25.97% | 2 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $48 → $42 | $17.33 | +142.35% | 3 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $207 → $230 | $507.42 | -54.67% | 1 | Jan 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $190 → $230 | $366.90 | -37.31% | 4 | Jul 26, 2019 |
Integra LifeSciences Holdings
Oct 7, 2024
Maintains: Underperform
Price Target: $26 → $18
Current: $24.12
Upside: -25.37%
Integer Holdings
Oct 1, 2024
Maintains: Buy
Price Target: $135 → $145
Current: $126.53
Upside: +14.60%
Merit Medical Systems
Sep 16, 2024
Maintains: Neutral
Price Target: $92 → $103
Current: $99.08
Upside: +3.96%
Haemonetics
Sep 11, 2024
Initiates: Neutral
Price Target: $85
Current: $73.53
Upside: +15.60%
PROCEPT BioRobotics
Aug 22, 2024
Maintains: Buy
Price Target: $80 → $94
Current: $97.07
Upside: -3.16%
GE HealthCare Technologies
May 1, 2024
Maintains: Neutral
Price Target: $94 → $86
Current: $86.99
Upside: -1.14%
The Cooper Companies
Oct 30, 2023
Initiates: Buy
Price Target: $95
Current: $104.86
Upside: -9.40%
Teleflex
Aug 3, 2023
Maintains: Neutral
Price Target: $265
Current: $207.33
Upside: +27.82%
Bausch + Lomb
Jul 3, 2023
Maintains: Buy
Price Target: $19 → $23
Current: $19.87
Upside: +15.75%
Globus Medical
Feb 13, 2023
Downgrades: Underperform
Price Target: $83 → $63
Current: $74.72
Upside: -15.69%
Mar 9, 2022
Maintains: Buy
Price Target: $30 → $25
Current: $6.06
Upside: +312.54%
Jan 18, 2022
Maintains: Buy
Price Target: $43 → $36
Current: $13.63
Upside: +164.12%
May 13, 2020
Reiterates: Overweight
Price Target: $23 → $45
Current: $9.12
Upside: +393.42%
Mar 25, 2020
Maintains: Overweight
Price Target: $1 → $8
Current: $0.87
Upside: +818.48%
Mar 24, 2020
Maintains: Neutral
Price Target: $60 → $30
Current: $12.32
Upside: +143.51%
Mar 24, 2020
Reiterates: Overweight
Price Target: $17 → $13
Current: $10.32
Upside: +25.97%
Feb 25, 2020
Maintains: Neutral
Price Target: $48 → $42
Current: $17.33
Upside: +142.35%
Jan 10, 2020
Reiterates: Overweight
Price Target: $207 → $230
Current: $507.42
Upside: -54.67%
Jul 26, 2019
Maintains: Neutral
Price Target: $190 → $230
Current: $366.90
Upside: -37.31%